| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.36▲ | 9.36▲ | 9.36▲ | 9.33▲ | 9.20▲ |
| MA10 | 9.34▲ | 9.34▲ | 9.34▲ | 9.26▲ | 8.08▲ |
| MA20 | 9.33▲ | 9.32▲ | 9.31▲ | 9.18▲ | 6.49▲ |
| MA50 | 9.30▲ | 9.27▲ | 9.24▲ | 7.73▲ | 3.12▲ |
| MA100 | 9.25▲ | 9.20▲ | 9.16▲ | 5.93▲ | 2.19▲ |
| MA200 | 9.18▲ | 9.14▲ | 8.66▲ | 3.37▲ | 2.33▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | 0.005▲ | 0.004▲ | -0.089▼ | 0.217▲ |
| RSI | 66.416▲ | 65.774▲ | 70.487▲ | 79.294▲ | 79.519▲ |
| STOCH | 83.750▲ | 91.250▲ | 80.926▲ | 88.573▲ | 90.963▲ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | 0.000▲ | -4.667▲ |
| CCI | 170.056▲ | 172.640▲ | 171.429▲ | 139.932▲ | 80.075 |
|
Tuesday, April 22, 2025 05:00 PM
March 26, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial ...
|
|
Thursday, April 10, 2025 05:00 PM
Founded in 2000, Optinose (NASDAQ: OPTN) of Yardley markets Xhance, a drug-device combination product approved by the Food and Drug Administration to treat nasal polyps and chronic sinusitis.
|
|
Wednesday, April 09, 2025 05:01 PM
Minerva Neurosciences has lower revenue, but higher earnings than OptiNose. OptiNose is trading at a lower price-to-earnings ratio than Minerva Neurosciences, indicating that it is currently the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 9.33 | 9.39 | 9.33 | 9.39 | 12,393 |
| 30/04/25 | 9.28 | 9.37 | 9.28 | 9.32 | 17,736 |
| 29/04/25 | 9.31 | 9.33 | 9.29 | 9.30 | 30,573 |
| 28/04/25 | 9.29 | 9.35 | 9.25 | 9.34 | 25,408 |
| 25/04/25 | 9.20 | 9.30 | 9.20 | 9.28 | 18,755 |
| 24/04/25 | 9.18 | 9.29 | 9.18 | 9.26 | 47,185 |
| 23/04/25 | 9.23 | 9.30 | 9.18 | 9.18 | 22,306 |
| 22/04/25 | 9.21 | 9.22 | 9.139 | 9.17 | 48,209 |
| 21/04/25 | 9.14 | 9.22 | 9.14 | 9.16 | 29,551 |
| 17/04/25 | 9.21 | 9.24 | 9.15 | 9.17 | 19,070 |
|
|
||||
|
|
||||
|
|